Duker Jay S.

Duker Jay S. is listed in filings as President and CEO at EyePoint Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 24, 2026, including purchase activity. Recent filings connect the profile to EyePoint Pharmaceuticals, Inc. (EYPT). The current snapshot covers public activity from Jul 12, 2024 to Mar 24, 2026. Reported amounts are shown as $70.0K to $53.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.